AIM: To evaluate the arguments for and against the possible roles of H pylori in hepatocellular carcinoma (HCC). METHODS: We performed a systematic review of all relevant studies published in the literature. A total of 103 clinical trials and reports were identified, but only 10 trials qualified under our selection criteria. A meta-analysis was carried out by a biostatistician according to the Cochrane Reviewers' Handbook recommended by The Cochrane Collaboration. RESULTS: Nine case-control studies and one retrospective cross sectional study were included in the final analysis. Overall the prevalence of H pylori infection was 53.3% (129 of 242) in cases and 10.4% (29 of 280) in controls, and the summary odds ratio for the association of H pylori infection with the risk for HCC (using the fixed-effects model, which accounted for the homogeneity across the 10 studies) was determined to be 13.63 (95% CI, 7.90-23.49). CONCLUSION: Our analysis showed a positive association between H pylori infection and the risk of HCC, with an indication of possible publication bias and possible confounders due to study designs that showed results of less pronounced associations.
AIM: To evaluate the arguments for and against the possible roles of H pylori in hepatocellular carcinoma (HCC). METHODS: We performed a systematic review of all relevant studies published in the literature. A total of 103 clinical trials and reports were identified, but only 10 trials qualified under our selection criteria. A meta-analysis was carried out by a biostatistician according to the Cochrane Reviewers' Handbook recommended by The Cochrane Collaboration. RESULTS: Nine case-control studies and one retrospective cross sectional study were included in the final analysis. Overall the prevalence of H pylori infection was 53.3% (129 of 242) in cases and 10.4% (29 of 280) in controls, and the summary odds ratio for the association of H pylori infection with the risk for HCC (using the fixed-effects model, which accounted for the homogeneity across the 10 studies) was determined to be 13.63 (95% CI, 7.90-23.49). CONCLUSION: Our analysis showed a positive association between H pylori infection and the risk of HCC, with an indication of possible publication bias and possible confounders due to study designs that showed results of less pronounced associations.
Authors: M Rocha; P Avenaud; A Ménard; B Le Bail; C Balabaud; P Bioulac-Sage; D M de Magalhães Queiroz; F Mégraud Journal: Gut Date: 2005-03 Impact factor: 23.059
Authors: J M Ward; J G Fox; M R Anver; D C Haines; C V George; M J Collins; P L Gorelick; K Nagashima; M A Gonda; R V Gilden Journal: J Natl Cancer Inst Date: 1994-08-17 Impact factor: 13.506
Authors: Rinaldo Pellicano; Vincenzo Mazzaferro; Walter Franco Grigioni; Miguel Angel Cutufia; Sharmila Fagoonee; Lorenzo Silengo; Mario Rizzetto; Antonio Ponzetto Journal: World J Gastroenterol Date: 2004-02-15 Impact factor: 5.742
Authors: Nicola Coppola; Giorgio De Stefano; Cecilia Marrocco; Ferdinando Scarano; Carlo Scolastico; Luciano Tarantino; Giovanni Rossi; Martina Battaglia; Mirella Onofrio; Flavia D'Aniello; Raffaella Pisapia; Caterina Sagnelli; Evangelista Sagnelli; Felice Piccinino; Antonio Giorgio; Pietro Filippini Journal: Infez Med Date: 2003-12
Authors: Eric A Engels; Sholom Wacholder; Hormuzd A Katki; Anil K Chaturvedi Journal: Cancer Epidemiol Biomarkers Prev Date: 2014-07-25 Impact factor: 4.254
Authors: Alexander Gutwerk; Thomas Wex; Kerstin Stein; Cosima Langner; Ali Canbay; Peter Malfertheiner; Alexander Link Journal: J Clin Med Date: 2018-03-05 Impact factor: 4.241